‘liberalization’

Drug Alcohol Depend. 2021 Oct 29;229(Pt B):109159. doi: 10.1016/j.drugalcdep.2021.109159. Online ahead of print. ABSTRACT BACKGROUND: Highly-potent cannabis products, e.g., concentrates, entail greater risks of cannabis-related harms than lower-potency products such as plant or flower material. However, little information is available on whether individuals in U.S. states with recreational cannabis laws Read more…

J Clin Aesthet Dermatol. 2021 Aug;14(8):49-51. Epub 2021 Aug 1. ABSTRACT BACKGROUND: Topical cannabinoid products are increasingly being recommended and used for a variety of dermatologic conditions. Despite this, safety and efficacy data of topical preparations are lacking, and the differences between topical and oral formulations are not well characterized. Read more…

J Ment Health. 2021 Nov 28:1-6. doi: 10.1080/09638237.2021.1979492. Online ahead of print. ABSTRACT The exaggerated language used in news articles to describe the benefits of cannabis for conditions without FDA indications may mislead the public and healthcare providers. Thus, this study’s objective was to investigate the use of exaggerated language Read more…

Curr Res Microb Sci. 2021 Jun 21;2:100045. doi: 10.1016/j.crmicr.2021.100045. eCollection 2021 Dec. ABSTRACT The use of cannabidiol oil derived products has dramatically increased in popularity and is predicted to grow steadily over the next decade. Given its relative stability, cannabidiol is likely to accumulate in the environment and affect aquatic Read more…

Phytother Res. 2021 Nov 29. doi: 10.1002/ptr.7263. Online ahead of print. ABSTRACT The debate on the use of cannabinoids for therapeutic purposes is constantly on the rise. This overview aimed to map the evidence on the therapeutic effects of cannabis derivatives and their synthetic analogs. Systematic reviews (SRs) of randomized Read more…

Integr Cancer Ther. 2021 Jan-Dec;20:15347354211061739. doi: 10.1177/15347354211061739. ABSTRACT BACKGROUND: Chemotherapy-induced peripheral neuropathy is a common and often severe side effect from many chemotherapeutic agents, with limited treatment options. There is no literature on the use of topical cannabinoids for chemotherapy-induced neuropathy. CASE PRESENTATIONS: The current manuscript presents a case series Read more…

J Diet Suppl. 2021 Nov 28:1-26. doi: 10.1080/19390211.2021.2005733. Online ahead of print. ABSTRACT The endocannabinoid system (ECS) is a widespread cell signaling network that maintains homeostasis in response to endogenous and exogenous stressors. This has made the ECS an attractive therapeutic target for various disease states. The ECS is a Read more…

iScience. 2021 Nov 1;24(12):103391. doi: 10.1016/j.isci.2021.103391. eCollection 2021 Dec 17. ABSTRACT Cannabis sativa L. has been one of the oldest medicinal plants cultivated for 10,000 years for several agricultural and industrial applications. However, the plant became controversial owing to some psychoactive components that have adverse effects on human health. In Read more…

Womens Health Rep (New Rochelle). 2021 Oct 4;2(1):452-458. doi: 10.1089/whr.2021.0042. eCollection 2021. ABSTRACT Background: As more US states legalize cannabis use, prevalence of use continues to rise and attitudes toward use are changing. This study examined (1) the relationship between cannabis use and social acceptability of use and (2) how Read more…

J Midwifery Womens Health. 2021 Nov 28. doi: 10.1111/jmwh.13293. Online ahead of print. ABSTRACT With a growing number of states legalizing recreational use, cannabis consumption during pregnancy is increasing. Population-based data and rigorous studies examining the association of cannabis use in pregnancy with perinatal outcomes are limited, but trends include Read more…